People · Operator

Klaus-Dieter Langner

Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology

1
Companies
2
Filings
$13.3M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Elastrin Therapeutics, Inc.—BiotechnologySeries A$13.3M$2.4M2023
Operator network

Klaus-Dieter Langner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Naren Vyavahare · 2 companies · 1 sharedNaren VyavaharePatrick Burgermeister · 2 companies · 1 sharedPatrick Burgermei…Matthias Breugelmans · 1 companies · 1 sharedMatthias Breugelm…Elastrin Therapeutics, Inc. · $13.3M raisedElastrin Therapeutics…Klaus-Dieter LangnerKL
Klaus-Dieter Langner Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Klaus-Dieter Langner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Naren Vyavahare12
Patrick Burgermeister12
Matthias Breugelmans11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.